SCHEMBL30878950

SCHEMBL30878950

CC(C)[Si](C#Cc1cc(=O)n(-c2ccccc2)c2nc(Nc3cnn(C)c3)ncc12)(C(C)C)C(C)C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 1/20 0.43
ALK Q9UM73 4/20 0.43
CDK19 Q9BWU1 3/20 0.43
CDK4 P11802 2/20 0.42
CCND1 P24385 2/20 0.42
CCND2 P30279 2/20 0.42
CCND3 P30281 2/20 0.42
GSK3B P49841 4/20 0.41
EGFR P00533 3/20 0.40
JAK1 P23458 3/20 0.40
JAK3 P52333 3/20 0.40
WEE1 P30291 1/20 0.40
TYK2 P29597 1/20 0.39
GSK3A P49840 2/20 0.39
JAK2 O60674 2/20 0.39
CDC7 O00311 1/20 0.39
DAPK3 O43293 1/20 0.39
ROCK2 O75116 1/20 0.39
PRKD3 O94806 1/20 0.39
MAP4K4 O95819 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30878852 0.88 EGFR (0.56) MAP4K1CDK4CCND1CCND2CCND3
SCHEMBL30878410 0.86 JAK3 (0.51) MAP4K1ALKCDK19CDK4CCND1
SCHEMBL30878988 0.83 CCND3 (0.51) CDK4CCND1CCND2CCND3EGFR
SCHEMBL30879031 0.83 WEE1 (0.48) MAP4K1CDK4CCND1CCND2CCND3
SCHEMBL30879189 0.83 CDK4 (0.52) CDK4CCND1CCND2CCND3EGFR
SCHEMBL30879036 0.82 WEE1 (0.47) WEE1BTK
SCHEMBL30878983 0.82 FLT3 (0.55) CDK4CCND1CCND2CCND3EGFR
SCHEMBL30878664 0.82 MAP4K1 (0.51) MAP4K1ALKEGFRJAK3CAMK2D
SCHEMBL30878783 0.81 CDK4 (0.51) CDK4CCND1CCND2CCND3EGFR
SCHEMBL30879080 0.81 BTK (0.47) MAP4K1CDK4CCND1CCND2CCND3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612148-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER Cancer Research Technology Limited (GB) 2025-09-10 EP disclosed
WO-2024094963-A1 2-AMINO-PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE AND 7-AMINO-1-PYRIMIDO[4,5-D]PYRIMIDIN-2(1 H)-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2024-05-10 WO disclosed